Pamtamine is a synthetic compound that acts as a dual inhibitor of the enzymes monoamine oxidase (MAO) and catechol-O-methyltransferase (COMT). It has potential applications in the treatment of neurological disorders, particularly those related to dopamine dysregulation, such as Parkinson's disease. Research into its efficacy and safety is ongoing, and it is not yet widely used in clinical practice.